Polyrizon Ltd. Ordinary Shares (PLRZ) Stock Price

PLRZStock
$10.90+65.12%52W
Market Cap$22.72M
P/E
PEG Ratio
Div yield
Beta0.56

PLRZ Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-34.54%
Price vs S&P 500 (4W)-8.03%
VGM Score44.36

Industry Peers — Surgical & Medical Instruments(140)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
PLRZPolyrizon Ltd. Ordinary Shares
C$10.90
SYKStryker CorporationCBC$330.59
MMM3M CompanyCDB$179.37
BSXBoston Scientific Corp.CBD$49.86
BDXBecton, Dickinson and Co.BDB$189.78
MDLNMedline Inc. Class A common stockCDC$35.64
RMDResMed Inc.CBC$236.59
DXCMDexCom, Inc.DBB$89.16
WSTWest Pharmaceutical Services, Inc.DCB$348.48
SOLVSolventum CorporationCCB$91.61
BAXBaxter International Inc.BDB$26.29

About Polyrizon Ltd. Ordinary Shares

Polyrizon Ltd is a clinical-stage biotech company developing nasal gel treatments designed to provide preventative protection against viruses including COVID-19 variants, influenza, and allergens. The company's proprietary platforms—Capture & Contain and Trap & Target—deliver broad-spectrum respiratory pathogen defense.